(Q34309232)

1 August 2017

title

IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation (English)

1 reference

1 August 2017

0 references

1 reference

Simone Maccaferri

1

1 reference

1 August 2017

Marco Candela

2

1 reference

1 August 2017

Silvia Turroni

3

1 reference

1 August 2017

Manuela Centanni

4

1 reference

1 August 2017

Marco Severgnini

5

1 reference

1 August 2017

Clarissa Consolandi

6

1 reference

1 August 2017

Piero Cavina

7

1 reference

1 August 2017

Patrizia Brigidi

8

1 reference

1 August 2017

publication date

20 June 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

3

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

406-413

1 reference

The human microbiome project

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Metatranscriptomic approach to analyze the functional human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Regulation of innate and adaptive immunity by the commensal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

A microbial symbiosis factor prevents intestinal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Metagenomics: key to human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Review article: probiotics and prebiotics in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Potential probiotic Kluyveromyces marxianus B0399 modulates the immune response in Caco-2 cells and peripheral blood mononuclear cells and impacts the human gut microbiota in an in vitro colonic model system.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

High taxonomic level fingerprint of the human intestinal microbiota by ligase detection reaction--universal array approach

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Development of a universal microarray based on the ligation detection reaction and 16S rrna gene polymorphism to target diversity of cyanobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Diversity of the human gastrointestinal tract microbiota revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Microbial community profiling for human microbiome projects: Tools, techniques, and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

The rationale and clinical effectiveness of probiotics in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

The immune system and the gut microbiota: friends or foes?

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Gut Microbiota in Health and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Human gut microbiota and its relationship to health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Gut microbiota is not modified by Randomized, Double-blind, Placebo-controlled Trial of VSL#3 in Diarrhea-predominant Irritable Bowel Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Impact of a synbiotic food on the gut microbial ecology and metabolic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

Direct profiling of the yeast dynamics in wine fermentations

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.21009

21 January 2018

Identifiers

DOI

10.4161/GMIC.21009

1 reference

1 August 2017

1 reference